Navigation Links
IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia
Date:8/12/2008

IDE CEO: "This Deal Places IDE in a Key Position for Competing for Similar

Projects in the Future, Establishes IDE's Presence on the Australian

Continent and Strengthens its Worldwide Deployment

TEL AVIV, Israel, August 12 /PRNewswire/ -- IDE Technologies, jointly owned (50:50) by The Israel Corporation Group subsidiary Israel Chemicals and the Delek Group, signed a contract to supply a desalination plant worth over a 100 million Euros to a major industrial client in Australia. The client will use the desalinated water for its production processes.

Slated for completion during 2010, the new plant will be based on reverse osmosis technology - a modern process technology used for desalinating water in a wide range of applications. The plant will provide 140,000 cubic meters/day (50 million cubic meters/year) of high quality desalinated process and drinking water, using innovative technologies implemented by IDE in its projects worldwide, for example in the plants in Ashkelon and Hadera (over 100 million cubic meters/year each), Cyprus (20 million cubic meters /year) and in Eilat (3.6 million cubic meters/year).

This project is one of the most complex in the world and one of the largest of its kind supplied by IDE to a foreign client. The quality of the feed water necessitates more precise and complex treatment than in similar installations elsewhere and will be subject to the rigid and meticulous standards of the local industry.

Avshalom Felber, Chief Executive Officer of IDE, welcomed the signing, calling the deal "one of the most challenging the company has known, which places IDE in a key position for competing for similar projects in the future. It establishes IDE's presence on the Australian continent strengthens its worldwide deployment in line with the company's business strategy of global expansion and strengthens IDE's position as a world leader in the seawater desalination market."

About IDE Technologies

Established in 1965, IDE Technologies is a world leader in water desalination. Jointly owned (50% each) by Israel Chemicals and the Delek Group, it specializes in commercial applications of thermal and membrane technologies for desalinating and converting sea- and brackish water to drinking and process water. Since its establishment the company has supplied more than 385 plants of different types and capacities, which supply high quality desalinated water to industries, mines, refineries, power stations and for urban and agricultural use. Spanning 40 countries on all continents, IDE's plants produce more than 1,600,000 cubic meters /day.

Contact

Mr. Henri Inzelberg

VP Marketing

IDE Technologies Ltd

t: +972-9-892-9791

henrii@ide-tech.com


'/>"/>
SOURCE IDE Technologies Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
2. Free White Paper: Hospital Tests Patient Lift Technologies; Improves Quality of Care
3. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
4. On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace
5. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride
8. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
9. Realtime Technologies Launches SHIMMER - a Wearable Health Sensor for Both Connected and Wireless Environments
10. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
11. Wound Management Technologies, Inc. Announces Filing of a 510K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special shopping trip ... the creation of published author, Janet Morrison, who has been writing mostly poetry, essays, ... Dog" series is her first attempt at writing for children. Janet, Fred, and two ...
(Date:12/7/2016)... ... 2016 , ... The Business Architecture Guild is ... on March 21-22, 2017. This premier event features business practitioners and experts from ... of industries such as financial services, insurance, healthcare, manufacturing, transportation, retail, and utilities. ...
(Date:12/7/2016)... ... December 07, 2016 , ... NuevaCare, a leading home care ... proud to announce new city-specific pages as part of its ambitious website relaunch. As ... often look, first, for local agencies serving their city. The new site has several ...
(Date:12/6/2016)... ... December 06, 2016 , ... People with ... be seen on a type of MRI, according to a study appearing online ... the central nervous system characterized by tremors or trembling and stiffness in the ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of a higher risk of serious health problems, such as cardiovascular illness, according ... Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes that the ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Two new disaster drones ... a simulated mass casualty event Tuesday at John Bell ... technology debuted before an audience including Mississippi ... from Homeland Security, Federal Law Enforcement Agencies, and the ... as HiRO (Health Integrated Rescue Operations), was developed by ...
(Date:12/6/2016)... , Dec. 6, 2016  Arcturus Therapeutics, Inc. ... company, announced today that it entered into collaboration ... therapeutics for the treatment of NASH and other ... delivery platform LUNAR™ and UNA Oligomer chemistry. The ... Takeda,s long-standing commitment to and expertise in GI ...
(Date:12/6/2016)... Dec. 6, 2016  Blueprint Medicines Corporation (NASDAQ: ... targeted kinase medicines for patients with genomically defined diseases, ... offering of $125,000,000 million in shares of its common ... underwriters a 30-day option to purchase up to an ... stock in connection with the public offering. All shares ...
Breaking Medicine Technology: